Top compounds associated with response to CTNND2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.08
mRNA MP470 GDSC1000 pan-cancer AAC 0.06 0.08
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.054 0.08
mRNA embelin GDSC1000 pan-cancer AAC -0.062 0.09
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.09
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.062 0.09
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.059 0.09
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.061 0.09
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.063 0.09
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.061 0.09
Download CSV